August 31, 2026

Criterium Energy secures long-term gas sales agreement with PGN

Criterium Energy reported continued progress at SE-MGH, now approximately 85% complete, alongside a new gas sales agreement with PGN and positive Q2 operating cash flow...

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: A Biotech Powerhouse with 52.45% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the dynamic biotech sector, drawing investor interest with its innovative focus on muscle activators and inhibitors for treating serious..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 46% Upside Awaits in the Dynamic Cardiac Monitoring Market

iRhythm Holdings, Inc. (NASDAQ: IRTC) is carving out a significant niche in the healthcare sector, specifically within the medical devices industry. The company’s focus on digital..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Play with 26.83% Potential Upside

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking growth in the..

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 12% Upside Potential for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is garnering investor interest with a promising..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Balance Between Growth Potential and Current Valuation

Investors eyeing the biotechnology sector are likely familiar with Bio-Techne Corp (NASDAQ: TECH), a formidable player in the healthcare industry. With a market capitalization of $11.35..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Promising 82% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) captures the attention of investors with a compelling narrative in the healthcare sector, particularly within biotechnology. With a market cap of..

Legend Biotech (LEGN): Analyst Consensus Predicts a 147.72% Potential Upside in Biotech Stock

Legend Biotech Corporation (NASDAQ: LEGN) is emerging as a compelling player in the biotechnology sector, particularly for investors who are keen on the dynamic field of..

Teleflex Incorporated (TFX) Stock Analysis: Exploring Growth Potential with a 9.93% Upside

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Potential Upside in Biotech Amidst Revenue Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, presents an intriguing opportunity for investors with a penchant for high-risk, high-reward ventures. With..

Corcept Therapeutics Incorporat (CORT) Growth Potential: Biotech Powerhouse with a 23.81% Upside

Investors with a keen eye on the healthcare sector might find Corcept Therapeutics Incorporat (NASDAQ: CORT) an intriguing proposition. With a robust market cap of $12.31..

BrightSpring Health Services, I (BTSG) Stock Analysis: A 32.76% Upside Potential Amid Strong Buy Ratings

BrightSpring Health Services, I (BTSG), a major player in the healthcare sector, is garnering significant attention from investors thanks to its robust growth prospects and unanimous..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 27% Upside Potential Amid Biotech Innovation

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling metabolic dysfunction-associated steatohepatitis (MASH). With..

Vaxcyte, Inc. (PCVX) Investor Outlook: Biotech Stock with an 82% Potential Upside

Investors looking for opportunities in the biotechnology sector should consider Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company that has garnered significant attention for its promising..

Glaukos Corporation (GKOS) Growth Potential: A Healthcare Innovator with a 9.61% Upside

As a pioneering force in the medical devices industry, Glaukos Corporation (NYSE: GKOS) stands at the intersection of innovation and healthcare. With its cutting-edge therapies targeting..

The Cooper Companies, Inc. (COO) Stock Analysis: Healthcare Giant with 14.51% Potential Upside

Investors keeping a keen eye on the healthcare sector may find The Cooper Companies, Inc. (NYSE: COO) an intriguing proposition. With a rich history dating back..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 17% Upside Potential Lights Up Investor Interest

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, stands out in the healthcare industry with its innovative pharmaceutical offerings. Based in Dublin,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking an 87.68% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX) presents an intriguing opportunity in the biotechnology space, especially for investors seeking exposure to the promising field of radiopharmaceuticals. With a..

Inspire Medical Systems, Inc. (INSP): Investor Outlook on Growth Prospects Amid Market Volatility

Inspire Medical Systems, Inc. (NYSE: INSP) stands at the intersection of technology and healthcare innovation, offering investors a unique opportunity to tap into the burgeoning medical..

Search

Funds

August 31, 2026

Criterium Energy secures long-term gas sales agreement with PGN

Criterium Energy reported continued progress at SE-MGH, now approximately 85% complete, alongside a new gas sales agreement with PGN and positive Q2 operating cash flow...
Search

Funds

August 31, 2026

FTSE 100

Funds